Beigene, LTD. (BEIGF) SEC Filings — 2024
26 SEC filings for Beigene, LTD. (BEIGF) in 2024.
Filings
- BeiGene Files 8-K: Other Events & Exhibits — 8-K · Dec 23, 2024
- Baker Bros. Advisors Adjusts BeiGene Stake — SC 13D/A · Dec 10, 2024
- BeiGene, Ltd. Files 8-K for Material Agreement — 8-K · Dec 10, 2024
- HHLR Advisors Ups BeiGene Stake to 10.4% — SC 13D/A · Dec 4, 2024
- BeiGene, Ltd. Files 8-K — 8-K · Nov 19, 2024
- BeiGene, Ltd. Files 8-K with Financials and Exhibits — 8-K · Nov 14, 2024
- BeiGene, Ltd. Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- BeiGene, Ltd. Amends Schedule 13D/A for Leap Therapeutics — SC 13D/A · Oct 31, 2024
- BeiGene, Ltd. Files 8-K Report — 8-K · Oct 28, 2024
- BeiGene, Ltd. Files 8-K on Sept 30, 2024 — 8-K · Sep 30, 2024
- BeiGene Announces Board and Officer Changes — 8-K · Sep 26, 2024
- BeiGene, Ltd. Files 8-K on Operations and Financials — 8-K · Aug 29, 2024
- BeiGene, Ltd. Files 10-Q for Q2 2024 — 10-Q · Aug 7, 2024
- BeiGene Announces Board Changes and Officer Compensation Details — 8-K · Jul 18, 2024
- BeiGene Announces Executive Changes and Shareholder Votes — 8-K · Jun 5, 2024
- BeiGene, Ltd. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- BeiGene, Ltd. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 26, 2024
- BeiGene, Ltd. Files 8-K on Financials — 8-K · Apr 26, 2024
- BeiGene, Ltd. Files 8-K with Financial Statements — 8-K · Apr 23, 2024
- BeiGene Appoints New CMO and CFO — 8-K · Mar 20, 2024
- BeiGene, Ltd. Files 8-K Report — 8-K · Mar 15, 2024
- BeiGene, Ltd. Files 8-K Report — 8-K · Mar 8, 2024
- BeiGene, Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Feb 26, 2024
- Capital International Investors Holds 10.0% Stake in BeiGene — SC 13G/A · Feb 9, 2024
- BeiGene CEO Oyler Holds 71.46M Shares, Signals Strong Insider Confidence — SC 13G/A · Feb 5, 2024
- BeiGene 8-K Signals Officer/Director Changes, Comp Arrangements — 8-K · Jan 23, 2024